Semiconductor laser therapy device

Model FNZ-IA1 is composed of control circuit, timing circuit, laser power supply and semiconductor laser. Model FNZ-IIA3 is composed of control circuit, pulse generator, energy regulation system, timing circuit, laser power supply, semiconductor laser and skin electrode sheet (purchased component). Main performance indicators: 1. FNZ-IA1 laser output power: three-stage adjustment, 3mW, 4mW and 5mW respectively. The error of 4mW and 5mW is ±30%; the output power of 3mW segment is 1mW-3mW. 2. FNZ-IIA3 laser output power: the laser terminal output power setting range is 3mW-5mW, and can be adjusted in five stages, 3mW, 3.5mW, 4mW, 4.5mW and 5mW respectively, with an error of ±30%. Other performance indicators

This product can improve blood rheology and microcirculation. It can improve cerebral infarction, headache, dizziness and pseudobulbar palsy in combination with drug treatment. Contraindications: Patients with malignant tumors, those who are allergic to light (such as lupus erythematosus, porphyria) and those with bradycardia. The following patients should consult a doctor before use: patients with acute diseases, infectious diseases, abnormal blood pressure, acute onset of cardiovascular and cerebrovascular diseases, skin perception disorders or skin abnormalities, and high fever patients.

FNZ-IA1, FNZ-IIA3